Akèy › Alòpesi Areat › Indiana › Indianapolis
Etid klinik pou Alòpesi Areat nan Indianapolis, IN
7 etid pou Alòpesi Areat ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
Ap rekriteFaz 3
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Ap rekriteFaz 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Ap rekriteFaz 1
- Dawes Fretzin Clinical Research Group, Indianapolis
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Ap rekriteFaz 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Ap rekriteFaz 3
- Indiana University Health University Hospital /ID# 259827, Indianapolis
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Ap rekriteFaz 3
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Ap rekriteFaz 3
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
Etid Alòpesi Areat nan lòt vil
- San Antonio, TX6 etid
- Miami, FL6 etid
- Omaha, NE5 etid
- New York City, NY4 etid
- Irvine, CA3 etid
- Troy, MI3 etid
- Columbus, OH3 etid
- Portland, OR3 etid
- Houston, TX3 etid
- Spokane, WA3 etid
- Los Angeles, CA3 etid
Lòt etid nan Indianapolis
- Kansè Poumon ki pa ti selil32 etid
- Kansè (tout kalite)24 etid
- Ensifizyans kadyak23 etid
- Kansè nan tete20 etid
- Obèsite20 etid
- Kansè Metastatik19 etid
- Kansè kolorektal18 etid
- Kansè ovè17 etid
- Kansè poumon16 etid
- Maladi kadyovaskilè16 etid
- Dyabèt tip 114 etid
- Kansè Endomèt14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.